| 摘要 |
The present invention relates to compounds of Formula (I), wherein R<2>, R<3>, R<4>, R<9>, Ar, UC, X, Y, Q, n and p are as defined in the specification. The compounds are useful as CCR-3 receptor antagonists, and therefore, may be used for treatment of CCR-3 mediated diseases. |
| 申请人 |
F. HOFFMANN-LA ROCHE AG;GONG, LEYI;WILHELM, ROBERT, STEPHEN |
发明人 |
GONG, LEYI;WILHELM, ROBERT, STEPHEN |
